Essential role of Sema4D in estrogen-mediated vaginal apoptosis. by Takuji Ito (566032)

“…OVX-oil treatment of WT mice significantly decreases apoptotic cell number in 5-week-old vaginal epithelia relative to that in Sham; compared with OVX-oil treatment, OVX-E2 treatment of WT mice induces a significant increase in apoptotic cell number in 5-week-old vaginal epithelia, comparable to the level of Sham. …”

ENMD-1198 inhibits c-Src-mediated STAT3 activation. by Saad Yousuf (541082)

“…A decrease in transcriptional activity was observed in cells **(p<0.00004) transfected with RKIP and treated with IL-6 when compared to cells treated with IL-6 (<i>bars</i>  =  mean ± S.D., of 2 experiments performed in triplicate). …”

Table_9_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_7_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_10_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_6_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_3_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_4_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_2_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_1_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_8_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Soybean tolerance to defoliation at the beginning of pod formation as affected by plant density by Murilo Miguel Durli (4703707)

“…The experimental design was a randomized block in a split-plot arrangement. …”

IP3Rs localization and function. by Ilanit Itzhaki (225708)

“…(<b>E–F</b>) Dose-response curves displaying the effects of 2-APB (0.1, 0.5, 1, 2, 5 and 10 µM) (E) and U73122 (0.5, 1, 2 and 3 µM) (F) on whole-cell [Ca²⁺]_i transients amplitude (displayed as the relative decrease (%) versus baseline values). …”

Force transients during length changes in different Ca²⁺ concentrations. by Fabio C. Minozzo (189129)

“…(B) Superimposed contractions showing the force decrease during shortening when a fibre was activated in pCa²⁺4.5 (solid line) and pCa²⁺6.0 (dashed line) (top), with the corresponding length changes (bottom). …”

Effects of tPA and cilostazol on endothelial cells at 18 h after reperfusion. by Mitsunori Ishiguro (359127)

“…Western blot analysis measured the levels of claudin-5. tPA alone at 6 h decreased claudin-5 levels. …”

LPO substrate specificity and susceptibility map of influenza strains. by Urmi Patel (5558513)

“…The quadrant circles indicate viral inactivations of different sizes (2.5, 5.0 and 7.5 logs). OSCN^-, hypothiocyanite; OI^-, hypoiodite; LPO, lactoperoxidase; PFU, plaque-forming unit; IAV, Influenza A virus; IBV, Influenza B virus.…”

Data_Sheet_1_Immediate reduction in left ventricular ejection time following TAVI is associated with improved quality of life.docx by Jimmy Schenk (13807486)

“…</p>Methods<p>During the TAVI procedure, blood pressure and systemic hemodynamics were prospectively collected with a Nexfin^® non-invasive monitor. HRQoL was evaluated pre-procedurally and 12 weeks after the procedure, using the EQ-5D-5L classification tool.…”

Maternal pre-pregnancy obesity, offspring cord blood DNA methylation, and offspring cardiometabolic health in early childhood: an epigenome-wide association study by Chantel L. Martin (5451938)

“…Epigenetic alterations, such as in DNA methylation (DNAm), are a hypothesized link; however, sex-specific epigenomic targets remain unclear. …”

Figure S1 - Synergistic and Additive Effects of Epigallocatechin Gallate and Digitonin on <em>Plasmodium</em> Sporozoite Survival and Motility by Janina K. Hellmann (254805)

“…However, decreasing the BSA concentration further resulted in a drastic reduction of gliding parasites. …”

Image_1_Prognostic Value of Right Ventricular Ejection Fraction Assessed by 3D Echocardiography in COVID-19 Patients.TIF by Yanting Zhang (338754)

“…</p><p>Results: Compared with controls, 2D-RVFWLS and 3D-RVEF were both significantly decreased in COVID-19 patients (−27.2 ± 4.4% vs. −22.9 ± 4.8%, P < 0.001; 53.7 ± 4.5% vs. 48.5 ± 5.8%, P < 0.001). …”